SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $3,517,000 | -33.7% | 195,489 | -12.5% | 1.29% | -4.7% |
Q4 2019 | $5,301,000 | -16.9% | 223,490 | -3.7% | 1.35% | -22.6% |
Q3 2019 | $6,376,000 | +1.3% | 232,030 | +21.9% | 1.75% | +0.3% |
Q2 2019 | $6,297,000 | +4.6% | 190,290 | +10.7% | 1.74% | +5.2% |
Q1 2019 | $6,022,000 | -33.9% | 171,870 | -37.4% | 1.65% | -41.5% |
Q4 2018 | $9,117,000 | -19.6% | 274,457 | +21.9% | 2.83% | -2.3% |
Q3 2018 | $11,340,000 | +76.9% | 225,232 | +110.3% | 2.90% | +68.0% |
Q2 2018 | $6,409,000 | +0.3% | 107,080 | -23.3% | 1.72% | +0.2% |
Q1 2018 | $6,391,000 | +18.9% | 139,535 | +3.5% | 1.72% | +18.0% |
Q4 2017 | $5,373,000 | +20.4% | 134,820 | +20.8% | 1.46% | +14.4% |
Q3 2017 | $4,464,000 | -11.5% | 111,600 | -4.6% | 1.28% | -15.3% |
Q2 2017 | $5,043,000 | +32.4% | 117,000 | -3.8% | 1.50% | +27.5% |
Q1 2017 | $3,808,000 | +24.2% | 121,660 | +0.2% | 1.18% | +15.3% |
Q4 2016 | $3,066,000 | +94.3% | 121,440 | +90.4% | 1.02% | +75.5% |
Q3 2016 | $1,578,000 | +117.4% | 63,795 | +79.0% | 0.58% | +107.5% |
Q2 2016 | $726,000 | – | 35,630 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |